Gene Query: CRYZ

Dataset Description Geneva Score
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 36.25
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 33.77
Differentially expressed genes post knock down of lincDUSP26 29.98
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 28.49
Safety profiling of genetically engineered Pim-1 kinase overexpression for oncogenicity risk in human c-kit+ cardiac interstitial cells 27.99
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 27.08
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 25.92
HNF1 regulates critical functions of the human epididymis epithelium. 25.92
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 25.79
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 25.16
An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells 23.69
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 23.65
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 23.24
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 21.96
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 21.96
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 21.58
Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes 21.01
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 20.66
The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks 18.27
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 17.94
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 17.93
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 17.78
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 17.71
Primary Human B-cell Temporal Response to CD40L Stimulation 17.65
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 17.61
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 17.52
STRIPAK directs PP2A activity to promote oncogenic transformation 17.5
Genome-wide analysis of the Integrator complex 16.69
Genome-wide analysis of the Integrator complex (HTS) 16.69
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 15.87
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 15.8
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 15.58
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 15.58
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 15.52
ELP1 splicing correction reverses proprioceptive sensory loss in familial dysautonomia 14.88
Gene Expression Profiling of SPOP Knocked Down Cell 14.82
Landscape of H3K4me3 in human CD19 cells 14.68
Transcriptome analysis of kidney organoids 14.58
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 14.41
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 14.02
Effect of Influenza virus infection on lncRNA expression in A549 cells 14.01
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 13.94
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 13.91
A sister of NANOG regulates genes expressed in pre-implantation human development 13.78
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 13.7
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 13.67
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 13.53
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 13.53
EWSR1 influences alternative splicing through direct and indirect mechanisms 13.49
Analysis of transcrptomes of Danon patient derived hiPSC-cardiomyocytes by RNA-deep Sequencing 13.18
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 12.9
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 12.86
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 12.86
Transcriptome analysis of virus infected tissues 12.8
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 12.78
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] 12.77
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing 12.77
Capturing the biology of mild versus severe disease in a pluripotent stem cell-based model of Familial Dysautonomia 12.75
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 12.65
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 12.59
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 12.55
Solid phase chemistry to covalently and reversibly capture thiolated RNA 12.39
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 12.33
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 12.32
Generation of induced keratinocyte stem cells from human urine cells by defined transcription factors 12.32
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 12.27
TGF-β promotes genomic instability after loss of RUNX3 12.27
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 12.26
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 12.26
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 11.85
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 11.85
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 11.81
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 11.7
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 11.65
RNA sequencing of primary human platelets and in vitro cell lines 11.63
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 11.54
Identification of Nrf2 regulated genes by RNA sequencing 11.51
Nrf2 regulated genes in A549 cells 11.51
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 11.36
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 11.36
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 11.13
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 11.13
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 11.04
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 10.98
Widespread regulated alternative splicing of single codons accelerates proteome evolution 10.98
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 10.77
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 10.5
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 10.41
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 10.09
Evolution of a transcriptional regulator from a transmembrane nucleoporin 10.09
RNA-seq in HepG2 and IMR90 cells 10.09
MeRIP-seq for heat shock in B-cell lymphoma cells 10.01
N6-methyladenine DNA Modification in Glioblastoma 9.96
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 9.96
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 9.94
METTL3 promotes translation in human cancer cells 9.85
Effect of ILF3 on translation during homeostasis and the antiviral response 9.81
Expression data from miR340 overexpressing human A549 cells 9.81
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 9.79
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 9.79
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 9.77
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 9.77
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 9.71
Comparing gene expression in iPSC derived RPE from control and AMD donors 9.69
Ro60-knockout cells 9.67
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 9.67
Expression by CD133+ cells isolated from the adult human exocrine pancreas 9.64
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 9.58
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 9.53
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 9.41
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 9.36
Seletive inhibition of CDK9 in DLBCL cell lines 9.34
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 9.22
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 9.2
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 9.11
Analysis of transcriptional regulation by Myt1 and Myt1l 9.01
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 9.0
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 8.99
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 8.98
The comparison of high-throughput single-cell RNA-seq methods 8.92
Effect of PRDM11 depletion in U2932 cells 8.88
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 8.85
RNA-Seq profiling of day 7 and day 18 kidney organoids differentiated in two batches 8.84
Identification of transcription start sites for human A549 cell line using ReCappable-seq 8.81
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 8.78
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 8.6
Regulation of protein translation during mitosis 8.55
Illumina Total RNA-seq in HeLa 8.54
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 8.5
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 8.31
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 8.27
Genome-wide transcriptome profiles in Control and Schizophrenia hiPSC-dervied NPC [RNA-seq] 8.2
Next-generation sequencing of control and schizophrenia hiPSC derived NPC 8.2
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 8.19
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 8.19
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 8.15
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 8.15
RNA-seq analyses of human prostate cancer cells 8.1
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 8.07
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 8.07
Direct Isolation and Characterization of Human Nephron Progenitors. 8.04
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 8.03
Gene expression changes in human melanoma cell lines compared to primary melanocytes 7.96
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 7.92
ARID1A and ARID1B loss in HCT116 and TOV21G cells 7.75
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 7.72
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 7.66
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 7.64
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 7.63
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 7.63
PNET animal model: new insights (II) 7.62
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 7.58
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 7.52
Next Generation Sequencing of human SMA and healthy control Motor Neurons 7.5
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 7.46
RNA-seq of tumor cells following angiopellosis extravasation 7.42
Genome-wide transcriptional response to random aneuploidy in human cells 7.37
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 7.36
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 7.29
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 7.29
BioProject PRJNA381064: Convergent origination of a Drosophila-like dosage compensation mechanism in a reptile lineage (Gene expression profiling in several tetrapod species, bulk tissue RNA-seq) 7.27
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 7.25
Large-scale profiling of intracellular signalling pathway activation reveals major distinctions between airway smooth muscle cells of asthmatics and non-asthmatics. 7.19
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 7.16
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 7.12
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 7.12
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 7.05
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 7.01
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 6.95
Improved LCL to iPSC reprogramming: RNA Analysis of LCLs, reprogrammed iPSCs, and differentiated NSCs reveal potential regulatory and functional processes involved in these cellular transitions. 6.93
Chromatin landscape of human visceral and subcutaneous adipocytes 6.88
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 6.87
RNA-Seq from early time points in the kidney differentiation protocol 6.84
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 6.83
A systematic analysis of the time series gene expression in TGF-beta induced EMT by Next-generation sequencing 6.82
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 6.81
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 6.79
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 6.79
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 6.78
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells 6.78
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 6.78
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 6.77
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 6.74
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 6.7
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 6.69
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 6.67
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 6.6
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 6.56
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 6.55
Region-specific Innate Antiviral Responses of the Human Epididymis 6.54
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 6.45
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 6.44
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 6.44
Accurate annotation of human protein-coding small open reading frames 6.44
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 6.42
Chromatin-informed inference of transcriptional programs in gynecologic cancers 6.42
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 6.42
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 6.41
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 6.41
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 6.38
A549 cells and MSR-A549 cells 6.38
RNA-Seq of PRMT1 overexpression ECA109 cells 6.37
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 6.36
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 6.36
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 6.36
RNA-Sequencing of HepG2 cells treated with TGFBeta 6.28
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 6.25
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 6.24
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 6.23
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 6.2
Reassessment of Exosome Composition 6.18
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 6.13
Gene expression patterns define the hepatocyte-like cells derived by different strategies 6.13
Gene expression patterns define the hepatocyte-like cells derived by different strategies [RNA-seq] 6.13
Spliceosomal disruption of the non-canonical BAF complex in cancer 6.12
High-Throughput Kinetic Analysis of Fractional Killing 6.11
Divergent expression and metabolic functions of human glucuronosyltransferases through alternative splicing 6.09
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 6.07
Human RELA haploinsufficiency results in autosomal dominant chronic mucocutaneous ulceration: the transcriptional profile of RelA haploinsufficient patients 6.07
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 6.07
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 6.03
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 6.03
Epigenomic conservation of transposable element silencing [RNA-seq] 6.03
Epigenomic conservation of transposable element silencing 6.03
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 6.02
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 5.97
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 5.92
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 5.87
Hijacking of stress response machinery by oncogenes in acute leukaemia 5.87
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 5.87
RNA-seq analysis of the human fetal kidney. 5.81
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 5.75
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 5.72
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 5.72
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 5.72
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 5.7
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 5.7
CD73 knockdown effect in pancreatic cancer cell lines 5.68
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 5.67
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 5.67
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 5.67
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 5.65
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 5.62
Transcriptomic profile of human embryonic renal corpuscles 5.57
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 5.57
Persistence of stem cell metabolism in cancers as a failure of differentiation 5.54
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma [RNA-Seq; normal samples] 5.53
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 5.49
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 5.49
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 5.45
Patient-derived luminal breast cancer xenografts with progestins 5.43
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 5.43
Primate transcript and protein expression levels evolve under compensatory selection pressures 5.4
IL-33 activates tumor stroma to promote intestinal polyposis 5.37
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 5.26
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 5.25
Comprehensive comparative analysis of 5’ end RNA sequencing methods 5.24
Transcriptome profiling of 5 human adenocarcinoma cell lines 5.24
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 5.22
Effect of CHKA knockdown on C4-2 cell transcriptome 5.19
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 5.16
Genome wide miR-191 target profile determined by RIP and gene expression profiling 5.16
Transcriptome wide analysis of classically and alternatively activated macrophages 5.13
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 5.12
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors 5.08
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 5.04
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 4.97
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 4.91
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 4.9
Genome-wide analysis of Dengue virus 2 infected cells 4.85
TGF-β regulation of miRNA expression in pancreatic cancer 4.84
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 4.83
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 4.83
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 4.82
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 4.8
Silencing SPIB in attached and floating state of H1703 lung cancer cells 4.78
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 4.73
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 4.58
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 4.53
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 4.5
Evolutionary origin and functional divergence of stem cell homeobox genes in eutherian mammals 4.38
An integrative analysis of non-coding regulatory DNA variations associated with autism 4.38
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 4.37
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 4.37
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 4.34
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 4.34
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 4.34
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 4.25
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes 4.25
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes [RNA-seq] 4.25
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 4.08
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 4.08
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 4.07
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 4.06
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver 4.04
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver [RNA-Seq] 4.04
CD74 role in transcription regulation 4.02
CD74 role in transcription regulation [RNA-seq] 4.02
Transcriptomic Dynamics during Differentiation Process of Human Pluripotent Cells into Hepatocyte-like Cells 4.01
Nonpregnant and term pregnant human myometrial tissues 4.0
Transcriptomic profiles of nonpregnant and term pregnant human myometrial tissues 4.0
SF3B1 Degron knockdown RNA-seq 3.95
mRNA expression profile of Lymphocytes 3.94
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 3.93
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 3.91
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 3.9
iPSC-Derived Cholangiocytes 3.8
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 3.78
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 3.78
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 3.73
Differential gene expression in Jagged1 treated human dental pulp cells. 3.72
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 3.7
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.67
Single-cell analysis of human kidney organoids 3.66
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 3.65
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 3.65
RNA-Seq of LRRK2 G2019S Parkinson’s iPSC-derived astrocytes 3.62
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 3.46
Identification of a LIF-responsive replication-competent human β cell 3.46
Transcriptome sequencing of K-562 cells 3.45
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 3.41
Molecular analysis of renal cell carcinoma with unclassfied histology 3.41
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 3.37
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 3.36
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 3.36
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 3.34
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 3.26
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 3.23
RNA sequencing of mechanically strained NHEKs and control NHEKs 3.23
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 3.22
Splicing and epigenetic factors jointly regulate epidermal differentiation 3.21
RNA-sequencing of healthy human skeletal myocytes 3.21
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 3.12
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 3.11
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 3.09
Next Generation Sequencing Compares Effects of microRNA-9 perturbation in control and SZ hiPSC NPCs 3.05
Expression profiles of cultured human epididymis cells reveal the functional diversity of caput, corpus and cauda regions. 3.04
Electronic cigarettes 3.04
A High-Throughput Screen Identifies DYRK inhibitor ID-8 that Stimulates Human Kidney Tubular Proliferation 3.03
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 3.02
Gene expression of collecting duct carcinoma of the kidney 2.97
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 2.96
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (BGI12 RNA-Seq) 2.94
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 2.93
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 2.93
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 2.9
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 2.89
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans 2.85
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 2.8
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 2.8
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 2.76
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype 2.7
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype [RNA-seq] 2.7
PRDM1 inhibits proliferation of human colon cancer organoids 2.7
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 2.7
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 2.69
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 2.69
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 2.68
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 2.65
Gene expression profile of human iPSC-derived nephron progenitor cells 2.64
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 2.59
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 2.53
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 2.52
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 2.51
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 2.49
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 2.49
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 2.46
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 2.42
Transcriptome of invasive mucinous adnocarcinoma of the lung and adjacent normal lung tissues from 6 patients based on RNA-seq method 2.37
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 2.33
Effect of hyperfractionated irradiation (HFRT) of prostate primary basal cells (PrEPs) on the transcriptome 2.3
single cell RNA-seq from GM12878 (ENCSR673UIY) 2.28
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 2.27
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 2.25
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 2.23
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 2.22
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 2.22
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 2.22
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 2.21
Effects of transcription on genome - nuclear lamina interactions 2.21
Hepatocyte maturation 2.16
Human Treg NaCl stimulation 2.13
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived NPCs 2.1
Derivation and differentiation of haploid human embryonic stem cells [RNA-Seq 1] 2.1
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 2.03
Exploring ILF2 regulatory genes by next-generation sequencing 2.03
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 2.0
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 1.98
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 1.97
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 1.95
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 1.94
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 1.94
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 1.94
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 1.94
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 1.92
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 1.92
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 1.89
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 1.86
Differential susceptibility of human pleural and peritoneal mesothelial cells to asbestos exposure 1.85
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 1.83
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 1.83
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 1.82
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 1.8
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 1.79
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 1.79
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 1.77
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 1.71
Identification of expressed and conserved human non-coding RNAs 1.71
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 1.69
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 1.69
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 1.6
In situ CAPTURE of chromatin interactions by biotinylated dCas9 1.6
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 1.59
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 1.59
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 1.58
mRNAseq of Huntington's disease and control patient iPSC-derived brain microvascular endothelial cells 1.5
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 1.48
The transcriptome of human endometrial mesenchymal stem cells under TGFβR inhibition reveals improved potential for cell-based therapies 1.47
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 1.46
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 1.45
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 1.45
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 1.44
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 1.42
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 1.38
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 1.34
Expression charcaterization of an internal protocol developed to differentiate RPE cells 1.34
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 1.3
HEK293 TFAM Knockout Expression Study 1.29
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 1.28
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 1.24
A genomic study of the contribution of DNA methylation to regulatory evolution in primates 1.21
The gene expression profiles of gallbladder cancer 1.17
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 1.15
The Genetic Landscape of Diamond-Blackfan Anemia 1.09
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 1.09
Transcriptional landscape changes during human embryonic stem cell derivation 1.04
p63 controls the enhancer landscape during keratinocyte differentiation 1.03
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 1.01
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 1.01
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 0.99
Transcriptome analysis revealed impaired cAMP responsiveness in PHF21A-deficient human cells 0.98
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 0.98
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 0.98
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 0.98
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 0.92
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 0.88
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.88
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.88
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 0.87
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.83
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 0.82
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 0.8
Transcriptomic profiling of human peripheral blood-derived mast cells 0.8
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.76
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 0.72
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.69
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 0.6
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.59
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 0.58
Transcriptional profiling of healthy, eutopic and ectopic endometrial organoids 0.49
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 0.46
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 0.45
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 0.43
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 0.43
The role of the Calcium-Sensing receptor in colorectal cancer 0.42
Expression data for hiPSC-derived RPE treated with 10mM Nicotinamide or vehicle 0.41
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 0.4
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 0.4
Gene profiling of human adult and pediatric liver cancer cells 0.37
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 0.34
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 0.31
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 0.3
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 0.29
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 0.29
Transcriptome sequencing of a large human family identifies the impact of rare non-coding variants 0.29
Reconstitution of the human pancreatic niche stimulates differentiation of hESCs into beta cells and reveals new signals for pancreatic endocrine cell maturation 0.24
FOXP2's impact on the primate transcriptome 0.22
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 0.22
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.21
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.21
Human Treg IL-12 stimulation 0.19
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 0.17
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 0.17
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.15
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 0.15
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 0.14
Hepatic transcriptome of pediatric hepatoblastoma. 0.14
Joint-specific DNA transcriptome signatures in rheumatoid arthritis [RNA-seq] 0.12
RNA-seq identifies novel lncRNAs involved in vascular smooth muscle cell proliferation 0.1
BMS-470539 on human synovial fibroblasts 0.1
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 0.1
Iron response of HepG2 cells 0.09
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 0.08
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 0.08
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 0.05
RNAseq data from Mesenchymal stem cells treated with TCDD or 1-methyl tryptophan 0.04
RNA-seq of cancer cell lines treated with T-025 0.04
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 0.01
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity 0.0
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation